Daniel J Stieh

Also affiliated with Janssen (Switzerland), Johnson & Johnson (Netherlands), Johnson & Johnson (Brazil)

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study”.

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

The Lancet HIV(2020)10.1016/s2352-3018(20)30229-0

N/A

2.7DataRank · unranked

91 citations

Daniel J Stieh, Michal Sarnecki, Stephen R. Walsh, Georgia D. Tomaras, James G. Kublin +36 more

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01262-1

N/A

2.6DataRank · unranked

93 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x

N/A

1.3DataRank · unranked

40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17–22)

The Lancet HIV(2020)10.1016/s2352-3018(20)30001-1

N/A

0.934DataRank · unranked

25 citations

Frank Wegmann, Frank Tomaka, Stephen R. Walsh, Chen Sabrina Tan, Ludo Lavreys +27 more

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac445

N/A

0.872DataRank · unranked

36 citations

Dan H. Barouch, Christy Comeaux, Michal Sarnecki, Kathryn E. Stephenson, Stephen R. Walsh +43 more

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial

Nature Communications(2024)10.1038/s41467-024-53727-y

N/A

0.644DataRank · unranked

21 citations

Ollivier Hyrien, Youyi Fong, David Benkeser, Sanne Roels, Daniel J Stieh +56 more

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

EBioMedicine(2024)10.1016/j.ebiom.2024.105320

N/A

0.425DataRank · unranked

16 citations

Janine van Duijn, One Dintwe, Jack Heptinstall, Randy I. Burnham, Sheetal Sawant +93 more

Mosaic HIV-1 vaccination induces anti-viral CD8 + T cell functionality in the phase 1/2a clinical trial APPROACH

Journal of Virology(2023)10.1128/jvi.01126-23

N/A

0.358DataRank · unranked

7 citations

Daniel J Stieh, Natalia Fernández, Deborah King, Jill Gilmour, Jeroen Tolboom +8 more

Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy

npj Vaccines(2024)10.1038/s41541-024-00876-2

N/A

0.330DataRank · unranked

8 citations

Kathryn E. Stephenson, Frank Tomaka, Stephen R. Walsh, Chen Sabrina Tan, Ludo Lavreys +24 more

Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1

Journal of Virology(2020)10.1128/jvi.01737-20

N/A

0.312DataRank · unranked

7 citations

Immaculate Nankya, Gabrielle Nickel, Annette N. Ratcliff, Adam Meadows, Nicholas J. Hathaway +11 more

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

iScience(2025)10.1016/j.isci.2025.113660

N/A

0.104DataRank · unranked

1 citations

Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Yiwen Lu +61 more

Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trial

EBioMedicine(2025)10.1016/j.ebiom.2025.106017

N/A

0.104DataRank · unranked

1 citations

Janine van Duijn, Kanika Vanshylla, One Dintwe, Laura Pattacini, Faatima Laher Omar +13 more

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.04.06.22272763

N/A

0DataRank · unranked

12 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Prediction of differential Gag versus Env responses to a mosaic HIV-1 vaccine regimen by HLA class I alleles

Journal of Virology(2024)10.1128/jvi.00281-24

N/A

0DataRank · unranked

0 citations

Janine van Duijn, Yuko Yuki, Maria Grazia Pau, Frank Tomaka, Ludo Lavreys +12 more

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Research Square(2023)10.21203/rs.3.rs-2743022/v1

N/A

0DataRank · unranked

0 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +38 more

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Nature Communications(2024)10.1038/s41467-024-46536-w

N/A

0DataRank · unranked

12 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +45 more